A Blind, Randomized and Controlled Clinical Trial to Evaluate the Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccines for Healthy Children

Trial Profile

A Blind, Randomized and Controlled Clinical Trial to Evaluate the Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccines for Healthy Children

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Sep 2017

At a glance

  • Drugs Varicella zoster vaccine Sinovac Biotech (Primary)
  • Indications Varicella zoster virus infections
  • Focus Therapeutic Use
  • Sponsors Sinovac (Dalian) Vaccine Technology
  • Most Recent Events

    • 25 Sep 2017 Results presented in a Sinovac Biotech media release.
    • 28 Nov 2016 According to a Sinovac Biotech media release, the company expects to complete this trial in the third quarter of 2017.
    • 19 Oct 2016 According to a Sinovac Biotech media release, status changed from planning to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top